Guardant Health
GH
#2539
Rank
NZ$9.58 B
Marketcap
$77.62
Share price
-3.29%
Change (1 day)
161.88%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -$8.07

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -$8.52. In 2022 the company made an earnings per share (EPS) of -$11.11 a decrease over its 2021 EPS that were of -$6.94.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$8.07-27.34%
2022-$11.1160%
2021-$6.9455.04%
2020-$4.48207.14%
2019-$1.46-19.81%
2018-$1.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$8.37-1.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.21-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA